The trend is what I care about; individual weeks are obviously noise.
I would rather over-plan the first cycle and simplify later.
I am prepared to do the work if someone can tell me which work matters.
What does a sensible plan look like, and what are the decision points?
Answer first: sarcopenia is defined by low muscle strength with low muscle quantity, and function rather than mass is the primary criterion in the current definitions.
The European working group definition uses low grip strength or low chair-stand performance as the entry criterion, confirms with low appendicular skeletal muscle mass adjusted for height, and grades severity by gait speed or a short physical performance battery.
Gait speed below about 0.8 metres per second is the usual severity marker and is the measure most strongly associated with adverse outcomes.
The current operational definition comes from the revised European consensus, which moved strength ahead of mass as the primary criterion.
Sarcopenic obesity is invisible on a scale. Measure or you will not see it.
Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.
Shop standardsThe short version: strength first, mass second, physical performance to grade severity. That ordering is deliberate and recent.
Age-related loss runs at roughly one per cent of muscle mass per year after the fifth decade, accelerating later, so a superimposed deficit-related loss compounds an existing trajectory.
Put another way, resistance training remains effective into the ninth decade; the response is slower and smaller than in younger adults but it is not absent, which is the single most useful fact in this tag.
Cut-points are population-referenced and differ between definitions, so a value near a threshold means little without the reference set.
Higher protein per meal with age, because of anabolic resistance.
The honest answer is that rapid weight loss in an older adult without resistance training is a genuine risk factor, and that the mitigation is entirely unglamorous.
Appendicular skeletal muscle mass index below roughly 7.0 kg/m² in men and 5.5 kg/m² in women is the usual confirmatory threshold on DXA.
Sarcopenic obesity is the combination that matters in this population: adequate or high total mass with low muscle mass, which no scale detects and which a body-mass index actively conceals.
Grip strength predicts mortality and disability more strongly than muscle mass in longitudinal cohorts, which is the empirical basis for that reordering.
Strength first, mass second, performance for severity. That is the definition.
The relevant concern in this population is sarcopenic obesity, where low muscle mass sits inside a high total mass and is therefore invisible without measurement.
Protein requirements are generally considered higher in older adults — often quoted at 1.2 to 1.5 g/kg for maintenance — because of anabolic resistance rather than because of increased losses.
Research-use compounds are not approved for human use, and none of them is a treatment for this.
Resistance training works at every age studied. Slower, smaller, still real.
edited 28 Jul 2026 by Dr_Yusuf_Adeyemi — added a caveat about sampling
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.